We are very happy to support the 2021 edition of the INTERNATIONAL OCULOPLASTIC COURSE along with our long-time partner in Argentina - CASIN OFTALMOLOGÍA + INNOVACIÓN.
FCI Ophthalmics is pleased to launch LacriJet® in the United States. It is the first, self-retaining monocanalicular nasolacrimal intubation preloaded on a single use injector.
|FCI, along with our long-time partner in Argentina CASIN OFTALMOLOGIA + INNOVACION, is very happy to support the 2021 edition of the INTERNATIONAL OCULOPLASTIC COURSE organized by the Department of Ophthalmology at the University of Buenos Aires, Argentina, under the leadership of Daniel WEIL, MD.
This program features monthly courses directed by world-renowned specialists in oculoplastic surgery, each session covering a distinctive topic in depth. See the image attached for the entire webinar schedule from now until December 8th. Contact your local sales representative, or FCI directly to learn more about how to register!
We are thrilled to announce that FCI will once again join the oculoplastic community at the upcoming ASOPRS Virtual Spring Meeting!